微血管自体组织乳房再造中的加速康复路径:是否应成为标准治疗?
该回顾性研究比较了自体组织乳房再造患者在接受加速康复路径前后的结局。加速康复路径组阿片类药物使用更少、住院时间更短,并带来病床释放和成本节约,45天主要并发症率等两组相似。作者认为加速康复路径应被视为自体组织乳房再造围手术期护理的标准方法。
要点
- 加速康复路径组术后阿片类药物使用显著少于传统标准治疗组,对乙酰氨基酚使用更多。
- 加速康复路径组住院时间中位数更短,参与加速康复路径和较低总吗啡当量用量是住院时间缩短的独立预测因素。
- 两组45天主要并发症率、皮瓣部分丢失率、急诊就诊、再入院和非计划再手术相似。
核心结论
- 加速康复路径项目的实施应被视为自体组织乳房再造围手术期护理的标准方法,因为它不影响并发症发生率,并与加速康复、减少术后阿片类药物使用和缩短住院时间相关,从而带来下游医疗成本节约。
研究设计与样本
- 回顾性综述,纳入2014年4月至2017年1月期间在大学中心由两名外科医生连续进行的自体组织乳房再造患者,比较加速康复路径实施前后各50例女性,共100例。
- 比较传统标准治疗(加速康复路径前)与加速康复路径患者的患者人口学、围手术期数据和45天术后结局。
- 进行多变量逻辑回归识别住院时间的危险因素,并进行成本分析。
主要发现
- 两组人口学、合并症和再造类型相似。
- 术后加速康复路径队列阿片类药物使用显著少于传统标准治疗队列,对乙酰氨基酚使用更多。
- 加速康复路径队列住院时间中位数更短,释放住院病床推算节约279,258美元,总体贡献边际增加189,342美元。
- 参与加速康复路径项目和较低总吗啡当量用量是住院时间缩短的独立预测因素。
- 两组45天主要并发症率、皮瓣部分丢失率、急诊就诊、再入院和非计划再手术相似。
临床怎么用
- 作者认为加速康复路径项目的实施应被视为自体组织乳房再造围手术期护理的标准方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enhanced recovery pathway programs have demonstrated improved perioperative care and shorter length of hospital stay in several surgical disciplines. The purpose of this study was to compare outcomes of patients undergoing autologous tissue-based breast reconstruction before and after the implementation of an enhanced recovery pathway program. METHODS: The authors retrospectively reviewed consecutive patients who underwent autologous tissue-based breast reconstruction performed by two surgeons before and after the implementation of the enhanced recovery pathway at a university center over a 3-year period. Patient demographics, perioperative data, and 45-day postoperative outcomes were compared between the traditional standard of care (pre-enhanced recovery pathway) and enhanced recovery pathway patients. Multivariate logistic regression was performed to identify risk factors for length of hospital stay. Cost analysis was performed. RESULTS: Between April of 2014 and January of 2017, 100 consecutive women were identified, with 50 women in each group. Both groups had similar demographics, comorbidities, and reconstruction types. Postoperatively, the enhanced recovery pathway cohort used significantly less opiate and more acetaminophen compared with the traditional standard of care cohort. Median length of stay was shorter in the enhanced recovery pathway cohort, which resulted in an extrapolated $279,258 savings from freeing up inpatient beds and increase in overall contribution margins of $189,342. Participation in an enhanced recovery pathway program and lower total morphine-equivalent use were independent predictors for decreased length of hospital stay. Overall 45-day major complication rates, partial flap loss rates, emergency room visits, hospital readmissions, and unplanned reoperations were similar between the two groups. CONCLUSION: Enhanced recovery pathway program implementation should be considered as the standard approach for perioperative care in autologous tissue-based breast reconstruction because it does not affect morbidity and is associated with accelerated recovery with reduced postoperative opiate use and decreased length of hospital stay, leading to downstream health care cost savings. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Kaoutzanis C, Ganesh Kumar N, O'Neill D, et al. Enhanced Recovery Pathway in Microvascular Autologous Tissue-Based Breast Reconstruction: Should It Become the Standard of Care? Plast Reconstr Surg. 2018. PMID: 29465485. doi:10.1097/PRS.0000000000004197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。